Key Operating Metrics:
As of June 30, | ||||||||||||
2021 | 2020 |
%
Change | ||||||||||
Active Buyers(2) | 23,942 | 14,460 | 66 | % | ||||||||
Percentage of Revenue from Existing Accounts(2) | 95 | % | 94 | % | 1 | % | ||||||
Accounts with Last Twelve-Months Spend of at Least $50,000(2) | 508 | 330 | 54 | % |
(2) Amounts shown for Active Buyers and Accounts with Last Twelve-Months Spend of at Least $50,000 are as of June 30, 2021 and 2020, and Percentage of Revenue from Existing Accounts is presented for the quarters ended June 30, 2021 and 2020.
Subsequent to Second Quarter 2021
On July 2, 2021, we closed our planned initial public offering ("IPO"), in which we issued and sold 7,906,250 shares of our Class A common stock. The initial offering price was $44.00 per share. We received net proceeds of approximately $325.3 million from the IPO after deducting underwriting discounts and commissions of $22.6 million.
Upon the closing of the IPO on July 2, 2021, 8,665,797 shares of our outstanding common stock were reclassified into Class A common stock, 27,758,941 shares of our outstanding convertible preferred stock were converted into Class A common stock, and 2,676,154 shares of Class A common stock were exchanged by our co-founders for an equivalent number of shares of Class B common stock pursuant to the terms of the exchange agreement.
Also on July 2, 2021, the Company reserved 402,658 shares of its Class A common stock, representing 1% of the Company's fully diluted capitalization as of the date of approval of our board of directors, for charitable contributions to non-profit organizations. These shares will be issued over the next five years, in an amount not to exceed 20% of the initial reserve amount per calendar year.
On July 9, 2021, we repaid our $15.9 million term loan outstanding and recorded a loss on extinguishment of approximately $0.3 million.
Financial Guidance and Outlook:
Q3 2021 | FY 2021 | |||||||||||||||
(in millions) | ||||||||||||||||
Low | High | Low | High | |||||||||||||
Revenue | $ | 53.0 | $ | 55.0 | $ | 207.5 | $ | 211.5 | ||||||||
Adjusted EBITDA | $ | (13.0 | ) | $ | (12.0 | ) | $ | (43.0 | ) | $ | (41.0 | ) | ||||
- In 2020, one customer, that produces masks, accounted for approximately 11% of our revenue with a majority of that revenue recognized in Q3 2020. Excluding revenue from that one customer, growth is expected to range between 66%-72% for Q3 2021, as compared to Q3 2020.